The most common side effect of FILSUVEZ is application site reactions, such as pain and itchy skin1
Adverse Event
FILSUVEZ
(n=109) n (%)
(n=109) n (%)
Placebo
(n=114) n (%)
(n=114) n (%)
All patients
(N=223) N (%)
(N=223) N (%)
Application Site Reaction*
8 (7.3)
7 (6.1)
15 (6.7)
- The incidence of application site reactions with FILSUVEZ was comparable to placebo gel1
- Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis1
- Long-term treatment with FILSUVEZ was well tolerated, with no new safety signals identified at the end of the 2-year extension period2
- Patients using FILSUVEZ experienced a low incidence of wound infections, which were typically mild to moderate through the long-term analysis2
*Includes application site pruritus, administration site pain, and administration site pruritus.1
See the before and after images of wounds treated with FILSUVEZ2
This image depicts the wound of a real patient with recessive dystrophic EB before and after treatment with FILSUVEZ in the EASE trial. Image used with permission.
Review dosing guidance and application instructions for FILSUVEZ
Dosing